| | | | | | | | | Sponsored | | We understand what’s at stake–timely detection of transplant-associated viral targets can be critical. Our transplant-focused ASR§ portfolio is designed to support the needs of mid-volume molecular labs to develop their own LDTs without compromising flexibility or workflow efficiency. See our full menu of ASRs§ available for BK virus, CMV, EBV, HHV-6, 7 & 8, JCV, and VZV. |
|
|
| | |
| |
| | |
|
|
| | | | | | Each summer, Medical Laboratory Observer (MLO) conducts a State of the Industry (SOI) survey on Disease Management. Our editorial team selects two disease areas to focus on for the survey. This year, we are asking for your input. |
|
|
| | The College of American Pathologists (CAP) announced that they will be hosting a virtual meeting regarding the status of hantavirus tomorrow, Tuesday, May 12, 2026. Two of their expert pathologists will be giving the briefing. |
|
|
| | In this article, originally published by our sister publication, Healthcare Innovation, Contributing Senior Editor David Raths gives an overview of Dr. Lesly Dossett’s recent webinar discussing her work with the Michigan Program for Value Enhancement, combating low-value preoperative testing. |
|
|
|
| |
| | |
|
|
| | | | | | Sponsored | | Healthcare providers face increasing pressure to make flawless clinical decisions, often with fragmented data and cognitive overload. Join Dr. Ari Frenkel, infectious disease physician and Chief Science Officer at Arkstone, on May 28 for a live webinar on how AI-powered clinical decision support is transforming the speed and quality of decision-making in infectious disease, when minutes matter most. |
|
|
| | |
| |
| | |
|
|
| | | | | | Medical Laboratory Observer is offering two free continuing education webinars in May, covering stroke care and STI diagnostics. Each live webinar is worth one CE credit. |
|
|
|
| |
| | |
|
|
| | | | | | Lucent Diagnostics and Tempus AI have partnered to integrate a blood-based biomarker panel into clinical workflows, aiming to improve early detection of Alzheimer’s disease and facilitate timely treatment decisions. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|